Hormone- and antibody-mediated activation of the thyrotropin receptor.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
09 2022
Historique:
received: 19 01 2022
accepted: 02 08 2022
pubmed: 9 8 2022
medline: 24 9 2022
entrez: 8 8 2022
Statut: ppublish

Résumé

Thyroid-stimulating hormone (TSH), through activation of its G-protein-coupled thyrotropin receptor (TSHR), controls the synthesis of thyroid hormone-an essential metabolic hormone

Identifiants

pubmed: 35940204
doi: 10.1038/s41586-022-05173-3
pii: 10.1038/s41586-022-05173-3
doi:

Substances chimiques

Immunoglobulins, Thyroid-Stimulating 0
LHCGR protein, human 0
Receptors, LH 0
Receptors, Thyrotropin 0
Thyrotropin 9002-71-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

854-859

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Tuncel, M. Thyroid stimulating hormone receptor. Mol. Imaging Radionucl. Ther. 26, 87–91 (2017).
pubmed: 28117293 pmcid: 5283706 doi: 10.4274/2017.26.suppl.10
Allgeier, A. et al. The human thyrotropin receptor activates G-proteins G
pubmed: 8188646 doi: 10.1016/S0021-9258(17)36705-4
Feldt-Rasmussen, U., Effraimidis, G. & Klose, M. The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions. Mol. Cell. Endocrinol. 525, 111173 (2021).
pubmed: 33549603 doi: 10.1016/j.mce.2021.111173
Taylor, P. N. et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301–316 (2018).
pubmed: 29569622 doi: 10.1038/nrendo.2018.18
Sanders, J. et al. Human monoclonal thyroid stimulating autoantibody. Lancet 362, 126–128 (2003).
pubmed: 12867115 doi: 10.1016/S0140-6736(03)13866-4
Neumann, S. et al. Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice. Proc. Natl Acad. Sci. USA 106, 12471–12476 (2009).
pubmed: 19592511 pmcid: 2708975 doi: 10.1073/pnas.0904506106
Evans, M. et al. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin. Endocrinol. 73, 404–412 (2010).
doi: 10.1111/j.1365-2265.2010.03831.x
Duan, J. et al. Structures of full-length glycoprotein hormone receptor signalling complexes. Nature 598, 688–692 (2021).
pubmed: 34552239 doi: 10.1038/s41586-021-03924-2
Latif, R., Ando, T., Daniel, S. & Davies, T. F. Localization and regulation of thyrotropin receptors within lipid rafts. Endocrinology 144, 4725–4728 (2003).
pubmed: 12960014 doi: 10.1210/en.2003-0932
Fan, Q. R. & Hendrickson, W. A. Structural biology of glycoprotein hormones and their receptors. Endocrine 26, 179–188 (2005).
pubmed: 16034172 doi: 10.1385/ENDO:26:3:179
Jiang, X. et al. Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor. Proc. Natl Acad. Sci. USA 109, 12491–12496 (2012).
pubmed: 22802634 pmcid: 3411987 doi: 10.1073/pnas.1206643109
Kleinau, G. et al. Defining structural and functional dimensions of the extracellular thyrotropin receptor region. J. Biol. Chem. 286, 22622–22631 (2011).
pubmed: 21525003 pmcid: 3121406 doi: 10.1074/jbc.M110.211193
Rapoport, B. & McLachlan, S. M. TSH receptor cleavage into subunits and shedding of the A-subunit; a molecular and clinical perspective. Endocr. Rev. 37, 114–134 (2016).
pubmed: 26799472 pmcid: 4823380 doi: 10.1210/er.2015-1098
Couet, J. et al. Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain. Biochemistry 35, 14800–14805 (1996).
pubmed: 8942642 doi: 10.1021/bi961359w
Morshed, S. A. & Davies, T. F. Graves’ disease mechanisms: the role of stimulating, blocking, and cleavage region TSH receptor antibodies. Horm. Metab. Res. 47, 727–734 (2015).
pubmed: 26361259 pmcid: 5047290 doi: 10.1055/s-0035-1559633
Couet, J. et al. Shedding of human thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease. J. Biol. Chem. 271, 4545–4552 (1996).
pubmed: 8626810 doi: 10.1074/jbc.271.8.4545
Kopp, P. The TSH receptor and its role in thyroid disease. Cell. Mol. Life Sci. 58, 1301–1322 (2001).
pubmed: 11577986 doi: 10.1007/PL00000941
Krieger, C. C., Neumann, S. & Gershengorn, M. C. Is there evidence for IGF1R-stimulating Abs in Graves’ orbitopathy pathogenesis? Int. J. Mol. Sci. 21, 6561 (2020).
pmcid: 7555308 doi: 10.3390/ijms21186561
Dechairo, B. M. et al. Association of the TSHR gene with Graves’ disease: the first disease specific locus. Eur. J. Hum. Genet. 13, 1223–1230 (2005).
pubmed: 16106256 doi: 10.1038/sj.ejhg.5201485
Neumann, S. & Gershengorn, M. C. Small molecule TSHR agonists and antagonists. Ann. Endocrinol. 72, 74–76 (2011).
doi: 10.1016/j.ando.2011.03.002
Chazenbalk, G. D. et al. Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites. Endocrinology 138, 2893–2899 (1997).
pubmed: 9202233 doi: 10.1210/endo.138.7.5259
Chen, C. R., Salazar, L. M., McLachlan, S. M. & Rapoport, B. Deleting the redundant TSH receptor C-peptide region permits generation of the conformationally intact extracellular domain by insect cells. Endocrinology 156, 2732–2738 (2015).
pubmed: 25860033 pmcid: 4475722 doi: 10.1210/en.2015-1154
Ozcabi, B. et al. Testotoxicosis: report of two cases, one with a novel mutation in LHCGR gene. J. Clin. Res. Pediatr. Endocrinol. 7, 242–248 (2015).
pubmed: 26831561 pmcid: 4677562 doi: 10.4274/jcrpe.2067
Kopp, P. et al. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281–>isoleucine) in the extracellular domain of the thyrotropin receptor. J. Clin. Invest. 100, 1634–1639 (1997).
pubmed: 9294132 pmcid: 508345 doi: 10.1172/JCI119687
Rasmussen, S. G. et al. Crystal structure of the β
pubmed: 21772288 pmcid: 3184188 doi: 10.1038/nature10361
Smits, G. et al. Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J. 22, 2692–2703 (2003).
pubmed: 12773385 pmcid: 156757 doi: 10.1093/emboj/cdg260
Pierce, J. G. & Parsons, T. F. Glycoprotein hormones: structure and function. Annu. Rev. Biochem. 50, 465–495 (1981).
pubmed: 6267989 doi: 10.1146/annurev.bi.50.070181.002341
Fox, K. M., Dias, J. A. & Van Roey, P. Three-dimensional structure of human follicle-stimulating hormone. Mol. Endocrinol. 15, 378–389 (2001).
pubmed: 11222739 doi: 10.1210/mend.15.3.0603
Lapthorn, A. J. et al. Crystal structure of human chorionic gonadotropin. Nature 369, 455–461 (1994).
pubmed: 8202136 doi: 10.1038/369455a0
Grossmann, M., Weintraub, B. D. & Szkudlinski, M. W. Novel insights into the molecular mechanisms of human thyrotropin action: structural, physiological, and therapeutic implications for the glycoprotein hormone family. Endocr. Rev. 18, 476–501 (1997).
pubmed: 9267761 doi: 10.1210/edrv.18.4.0305
Mueller, S., Jaeschke, H., Gunther, R. & Paschke, R. The hinge region: an important receptor component for GPHR function. Trends Endocrinol. Metab. 21, 111–122 (2010).
pubmed: 19819720 doi: 10.1016/j.tem.2009.09.001
Bruser, A. et al. The activation mechanism of glycoprotein hormone receptors with implications in the cause and therapy of endocrine diseases. J. Biol. Chem. 291, 508–520 (2016).
pubmed: 26582202 doi: 10.1074/jbc.M115.701102
van Koppen, C. J. et al. Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptor. Br. J. Pharmacol. 165, 2314–2324 (2012).
pubmed: 22014107 pmcid: 3413865 doi: 10.1111/j.1476-5381.2011.01709.x
Sanders, P. et al. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. J. Mol. Endocrinol. 46, 81–99 (2011).
pubmed: 21247981
Vlaeminck-Guillem, V., Ho, S. C., Rodien, P., Vassart, G. & Costagliola, S. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol. Endocrinol. 16, 736–746 (2002).
pubmed: 11923470 doi: 10.1210/mend.16.4.0816
Punjani, A. & Fleet, D. J. 3D variability analysis: resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM. J. Struct. Biol. 213, 107702 (2021).
pubmed: 33582281 doi: 10.1016/j.jsb.2021.107702
Sanders, J. et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17, 395–410 (2007).
pubmed: 17542669 doi: 10.1089/thy.2007.0034
Neumann, S. et al. An enantiomer of an oral small-molecule TSH receptor agonist exhibits improved pharmacologic properties. Front. Endocrinol. 7, 105 (2016).
doi: 10.3389/fendo.2016.00105
Jaeschke, H. et al. An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function. Endocrinology 147, 1753–1760 (2006).
pubmed: 16410307 doi: 10.1210/en.2005-1138
Kleinau, G. et al. Identification of a novel epitope in the thyroid-stimulating hormone receptor ectodomain acting as intramolecular signaling interface. J. Biol. Chem. 279, 51590–51600 (2004).
pubmed: 15345720 doi: 10.1074/jbc.M404748200
Kleinau, G. & Krause, G. Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. Endocr. Rev. 30, 133–151 (2009).
pubmed: 19176466 doi: 10.1210/er.2008-0044
Schulze, A. et al. The intramolecular agonist is obligate for activation of glycoprotein hormone receptors. FASEB J. 34, 11243–11256 (2020).
pubmed: 32648604 doi: 10.1096/fj.202000100R
Ballesteros, J. A. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366–428 (1995).
doi: 10.1016/S1043-9471(05)80049-7
Weis, W. I. & Kobilka, B. K. The molecular basis of G protein-coupled receptor activation. Annu. Rev. Biochem. 87, 897–919 (2018).
pubmed: 29925258 pmcid: 6535337 doi: 10.1146/annurev-biochem-060614-033910
Katritch, V. et al. Allosteric sodium in class A GPCR signaling. Trends Biochem. Sci. 39, 233–244 (2014).
pubmed: 24767681 pmcid: 4106411 doi: 10.1016/j.tibs.2014.03.002
Kosugi, S., Shenker, A. & Mori, T. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor. FEBS Lett. 356, 291–294 (1994).
pubmed: 7805857 doi: 10.1016/0014-5793(94)01286-5
Urizar, E. et al. An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor. J. Biol. Chem. 280, 17135–17141 (2005).
pubmed: 15722344 doi: 10.1074/jbc.M414678200
Roberts, S. A., Moon, J. E., Dauber, A. & Smith, J. R. Novel germline mutation (Leu512Met) in the thyrotropin receptor gene (TSHR) leading to sporadic non-autoimmune hyperthyroidism. J. Pediatr. Endocrinol. Metab. 30, 343–347 (2017).
pubmed: 28195550 pmcid: 5856010 doi: 10.1515/jpem-2016-0185
Neumann, S., Krause, G., Chey, S. & Paschke, R. A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation. Mol. Endocrinol. 15, 1294–1305 (2001).
pubmed: 11463854 doi: 10.1210/mend.15.8.0672
Carpenter, B., Nehme, R., Warne, T., Leslie, A. G. & Tate, C. G. Structure of the adenosine A
pubmed: 27462812 pmcid: 4979997 doi: 10.1038/nature18966
Liang, Y. L. et al. Dominant negative G proteins enhance formation and purification of agonist-GPCR-G protein complexes for structure determination. ACS Pharmacol. Transl. Sci. 1, 12–20 (2018).
pubmed: 32219201 pmcid: 7089020 doi: 10.1021/acsptsci.8b00017
Maeda, S., Qu, Q., Robertson, M. J., Skiniotis, G. & Kobilka, B. K. Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes. Science 364, 552–557 (2019).
pubmed: 31073061 pmcid: 7034192 doi: 10.1126/science.aaw5188
Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005).
pubmed: 16182563 doi: 10.1016/j.jsb.2005.07.007
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
pubmed: 28250466 pmcid: 5494038 doi: 10.1038/nmeth.4193
Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).
pubmed: 26592709 pmcid: 4711343 doi: 10.1016/j.jsb.2015.11.003
Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519–530 (2012).
pubmed: 23000701 pmcid: 3690530 doi: 10.1016/j.jsb.2012.09.006
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
pubmed: 28165473 doi: 10.1038/nmeth.4169
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
pubmed: 15264254 doi: 10.1002/jcc.20084
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126–2132 (2004).
pubmed: 15572765 doi: 10.1107/S0907444904019158
Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D 74, 519–530 (2018).
doi: 10.1107/S2059798318002425
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).
pubmed: 20124702 pmcid: 2815670 doi: 10.1107/S0907444909052925
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010).
pubmed: 20057044 doi: 10.1107/S0907444909042073
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2020).
pubmed: 32881101 pmcid: 7737788 doi: 10.1002/pro.3943
Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I. & Lomize, A. L. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 40, D370–D376 (2012).
pubmed: 21890895 doi: 10.1093/nar/gkr703
Jo, S. et al. CHARMM-GUI 10 years for biomolecular modeling and simulation. J. Comput. Chem. 38, 1114–1124 (2017).
pubmed: 27862047 doi: 10.1002/jcc.24660
Pascal, B. D. et al. HDX workbench: software for the analysis of H/D exchange MS data. J. Am. Soc. Mass. Spectrom. 23, 1512–1521 (2012).
pubmed: 22692830 doi: 10.1007/s13361-012-0419-6

Auteurs

Jia Duan (J)

The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
University of Chinese Academy of Sciences, Beijing, China.

Peiyu Xu (P)

The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.

Xiaodong Luan (X)

Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Medical Research Center, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
School of Medicine, Tsinghua University, Beijing, China.
Tsinghua-Peking Center for life science, Tsinghua University, Beijing, China.

Yujie Ji (Y)

The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
University of Chinese Academy of Sciences, Beijing, China.

Xinheng He (X)

The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
University of Chinese Academy of Sciences, Beijing, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

Ning Song (N)

University of Chinese Academy of Sciences, Beijing, China.
Center of Immunological Diseases, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

Qingning Yuan (Q)

The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

Ye Jin (Y)

Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Medical Research Center, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

Xi Cheng (X)

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

Hualiang Jiang (H)

University of Chinese Academy of Sciences, Beijing, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
School of Life Science and Technology, ShanghaiTech University, Shanghai, China.

Jie Zheng (J)

Center of Immunological Diseases, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

Shuyang Zhang (S)

Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. shuyangzhang103@nrdrs.org.
Medical Research Center, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. shuyangzhang103@nrdrs.org.
School of Medicine, Tsinghua University, Beijing, China. shuyangzhang103@nrdrs.org.
Tsinghua-Peking Center for life science, Tsinghua University, Beijing, China. shuyangzhang103@nrdrs.org.

Yi Jiang (Y)

School of Life Science and Technology, ShanghaiTech University, Shanghai, China. yjiang@lglab.ac.cn.
Lingang Laboratory, Shanghai, China. yjiang@lglab.ac.cn.

H Eric Xu (HE)

The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. eric.xu@simm.ac.cn.
University of Chinese Academy of Sciences, Beijing, China. eric.xu@simm.ac.cn.
School of Life Science and Technology, ShanghaiTech University, Shanghai, China. eric.xu@simm.ac.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH